|
1
|
Malwal SR, O'Dowd B, Feng X, Turhanen P,
Shin C, Yao J, Kim BK, Baig N, Zhou T, Bansal S, et al:
Bisphosphonate-generated ATP-analogs inhibit cell signaling
pathways. J Am Chem Soc. 140:7568–7578. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tamai R, Sugiyama A and Kiyoura Y: Effects
of nitrogen-containing bisphosphonates on the response of human
peripheral blood mononuclear cells and gingival fibroblasts to
bacterial components. J Oral Biosci. 52:268–274. 2010.
|
|
3
|
Frith JC and Rogers MJ: Antagonistic
effects of different classes of bisphosphonates in osteoclasts and
macrophages in vitro. J Bone Miner Res. 18:204–212. 2003.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tamai R, Mashima I and Kiyoura Y:
Alendronate augments lipid A-induced IL-1α release via activation
of ASC but not caspase-11. Inflammation. 44:2132–2141.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gendaszewska-Darmach E, Garstka MA and
Blazewska KM: Targeting small GTPases and their prenylation in
diabetes mellitus. J Med Chem. 64:9677–9710. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ruggiero SL, Dodson TB, Aghaloo T, Carlson
ER, Ward BB and Kademani D: American association of oral and
maxillofacial surgeons' position paper on medication-related
osteonecrosis of the Jaws-2022 update. J Oral Maxillofac Surg.
80:920–943. 2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pontillo A, Paoluzzi E and Crovella S: The
inhibition of mevalonate pathway induces upregulation of NALP3
expression: new insight in the pathogenesis of mevalonate kinase
deficiency. Eur J Hum Genet. 18:844–847. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang J, Zhu HH, Chen GP, Ye Y, Zhao CZ,
Mou Y and Hu SJ: Inhibition of farnesyl pyrophosphate synthase
attenuates angiotensin II-induced cardiac hypertrophy and fibrosis
in vivo. Int J Biochem Cell Biol. 45:657–666. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang Q, Yu W, Lee S, Xu Q, Naji A and Le
AD: Bisphosphonate induces osteonecrosis of the jaw in diabetic
mice via NLRP3/caspase-1-dependent IL-1β mechanism. J Bone Miner
Res. 30:2300–2312. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tamai R and Kiyoura Y: Alendronate
augments lipid A-induced IL-1β release and
Smad3/NLRP3/ASC-dependent cell death. Life Sci. 198:8–17.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sing CW, Kiel DP, Hubbard RB, Lau WC, Li
GH, Kung AW, Wong IC and Cheung CL: Nitrogen-containing
bisphosphonates are associated with reduced risk of pneumonia in
patients with hip fracture. J Bone Miner Res. 35:1676–1684.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tamai R, Suzuki K, Mashima I and Kiyoura
Y: MPMBP down-regulates toll-like receptor (TLR) 2 ligand-induced
proinflammatory cytokine production by inhibiting NF-κB but not
AP-1 activation. Int Immunopharmacol. 79(106085)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tamai R, Sakuta T, Matsushita K, Trii M,
Takeuchi O, Akira S, Akashi S, Espevik T, Sugawara S and Takada H:
Human gingival CD14+ fibroblasts primed with gamma
interferon increase production of interleukin-8 in response to
lipopolysaccharide through up-regulation of membrane CD14 and MyD88
mRNA expression. Infect Immun. 70:1272–1278. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kayagaki N, Warming S, Lamkanfi M, Vande
Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, et al:
Non-canonical inflammasome activation targets caspase-11. Nature.
479:117–121. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Baroja-Mazo A, Martin-Sanchez F, Gomez AI,
Martinez CM, Amores-Iniesta J, Compan V, Barbera-Cremades M, Yague
J, Ruiz-Ortiz E, Anton J, et al: The NLRP3 inflammasome is released
as a particulate danger signal that amplifies the inflammatory
response. Nat Immunol. 15:738–748. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Xia S, Zhang Z, Magupalli VG, Pablo JL,
Dong Y, Vora SM, Wang L, Fu TM, Jacobson MP, Greka A, et al:
Gasdermin D pore structure reveals preferential release of mature
interleukin-1. Nature. 593:607–611. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chan JNE, Humphry M, Kitt L, Krzyzanska D,
Filbey KJ, Bennett MR and Clarke MCH: Cell surface IL-1α
trafficking is specifically inhibited by interferon-γ, and
associates with the membrane via IL-1R2 and GPI anchors. Eur J
Immunol. 50:1663–1675. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Weinstein RS, Roberson PK and Manolagas
SC: Giant osteoclast formation and long-term oral bisphosphonate
therapy. N Engl J Med. 360:53–62. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Rogers MJ, Gordon S, Benford HL, Coxon FP,
Luckman SP, Monkkonen J and Frith JC: Cellular and molecular
mechanisms of action of bisphosphonates. Cancer. 88:2961–2978.
2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Brennan A, Leech JT, Kad NM and Mason JM:
Selective antagonism of cJun for cancer therapy. J Exp Clin Cancer
Res. 39(184)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hasegawa M, Imamura R, Motani K, Nishiuchi
T, Matsumoto N, Kinoshita T and Suda T: Mechanism and repertoire of
ASC-mediated gene expression. J Immunol. 182:7655–7662.
2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shi H, Sun L, Wang Y, Liu A, Zhan X, Li X,
Tang M, Anderton P, Hildebrand S, Quan J, et al: N4BP1 negatively
regulates NF-κB by binding and inhibiting NEMO oligomerization. Nat
Commun. 12(1379)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gitlin AD, Heger K, Schubert AF, Reja R,
Yan D, Pham VC, Suto E, Zhang J, Kwon YC, Freund EC, et al:
Integration of innate immune signaling by caspase-8 cleavage of
N4BP1. Nature. 587:275–280. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gou C, Ni W, Ma P, Zhao F, Wang Z, Sun R,
Wu Y, Wu Y, Chen M, Chen H, et al: The endoribonuclease N4BP1
prevents psoriasis by controlling both keratinocytes proliferation
and neutrophil infiltration. Cell Death Dis. 12(488)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pelegrin P, Barroso-Gutierrez C and
Surprenant A: P2X7 receptor differentially couples to distinct
release pathways for IL-1β in mouse macrophage. J Immunol.
180:7147–7157. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Porras AG, Holland SD and Gertz BJ:
Pharmacokinetics of alendronate. Clin Pharmacokinet. 36:315–328.
1999.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vasudevan SO, Russo AJ, Kumari P, Vanaja
SK and Rathinam VA: A TLR4-independent critical role for CD14 in
intracellular LPS sensing. Cell Rep. 39(110755)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Enosi Tuipulotu D, Feng S, Pandey A, Zhao
A, Ngo C, Mathur A, Lee J, Shen C, Fox D, Xue Y, et al: Immunity
against Moraxella catarrhalis requires guanylate-binding
proteins and caspase-11-NLRP3 inflammasomes. EMBO J.
42(e112558)2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhao W, Beers DR, Bell S, Wang J, Wen S,
Baloh RH and Appel SH: TDP-43 activates microglia through NF-κB and
NLRP3 inflammasome. Exp Neurol. 273:24–35. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yang H, Xiao L, Yuan Y, Luo X, Jiang M, Ni
J and Wang N: Procyanidin B2 inhibits NLRP3 inflammasome activation
in human vascular endothelial cells. Biochem Pharmacol. 92:599–606.
2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhou X, Hong T, Yu Q, Nie S, Gong D, Xiong
T and Xie M: Exopolysaccharides from Lactobacillus plantarum
NCU116 induce c-Jun dependent Fas/Fasl-mediated apoptosis via TLR2
in mouse intestinal epithelial cancer cells. Sci Rep.
7(14247)2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Matsumoto N, Imamura R and Suda T:
Caspase-8- and JNK-dependent AP-1 activation is required for Fas
ligand-induced IL-8 production. FEBS J. 274:2376–2384.
2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Plotkin LI, Weinstein RS, Parfitt AM,
Roberson PK, Manolagas SC and Bellido T: Prevention of osteocyte
and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin
Invest. 104:1363–1374. 1999.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Wu Y, Qiu G, Zhang H, Zhu L, Cheng G, Wang
Y, Li Y and Wu W: Dexmedetomidine alleviates hepatic
ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway. J
Cell Mol Med. 25:9983–9994. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Han X, Li B, Bao J, Wu Z, Chen C, Ni J,
Shen J, Song P, Peng Q, Wan R, et al: Endoplasmic reticulum stress
promoted acinar cell necroptosis in acute pancreatitis through
cathepsinB-mediated AP-1 activation. Front Immunol.
13(968639)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Oh CC, Lee J, D'Souza K, Zhang W, Migrino
RQ, Thornburg K and Reaven P: Activator protein-1 and caspase 8
mediate p38α MAPK-dependent cardiomyocyte apoptosis induced by
palmitic acid. Apoptosis. 24:395–403. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liao M, Liao J, Qu J, Shi P, Cheng Y, Pan
Q, Zhao N, Zhang X, Zhang L, Tan Y, et al: Hepatic TNFRSF12A
promotes bile acid-induced hepatocyte pyroptosis through
NFκB/caspase-1/GSDMD signaling in cholestasis. Cell Death Discov.
9(26)2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Purbasari B, Madhyastha R, Madhyastha H,
Nurrahmah QI, Maruyama M, Nakajima Y, Kataoka H and Watanabe N:
Retinoic acid attenuates nuclear factor κB mediated induction of
NLRP3 inflammasome. Pharmacol Rep. 74:189–203. 2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Fanjul A, Dawson MI, Hobbs PD, Jong L,
Cameron JF, Harlev E, Graupner G, Lu XP and Pfahl M: A new class of
retinoids with selective inhibition of AP-1 inhibits proliferation.
Nature. 372:107–111. 1994.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Tsuchida K, Chaki H, Takakura T, Yokotani
J, Aikawa Y, Shiozawa S, Gouda H and Hirono S: Design, synthesis,
and biological evaluation of new cyclic disulfide decapeptides that
inhibit the binding of AP-1 to DNA. J Med Chem. 47:4239–4246.
2004.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu X, Wang Y, Lu H, Li J, Yan X, Xiao M,
Hao J, Alekseev A, Khong H, Chen T, et al: Genome-wide analysis
identifies NR4A1 as a key mediator of T cell dysfunction. Nature.
567:525–529. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Shirato K and Kizaki T: SARS-CoV-2 spike
protein S1 subunit induces pro-inflammatory responses via Toll-like
receptor 4 signaling in murine and human macrophages. Heliyon.
7(e06187)2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Tamai R and Kiyoura Y: Heat-killed
Candida albicans augments synthetic bacterial
component-induced proinflammatory cytokine production. Folia
Microbiol (Praha). 64:555–566. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Karga H, Giagourta I, Papaioannou G,
Katsichti P, Pardalakis A, Kassi G, Zagoreou A, Triantaphyllopoulou
M and Zerva C: Transient changes in thyroid functions tests after
zoledronic acid infusion. Endocr J. 58:969–977. 2011.PubMed/NCBI View Article : Google Scholar
|
